Y. Karaman-Kutluay Et Al. , "Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice," European-Respiratory-Society (ERS) International Congress , vol.54, Madrid, Spain, 2019
Karaman-Kutluay, Y. Et Al. 2019. Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice. European-Respiratory-Society (ERS) International Congress , (Madrid, Spain).
Karaman-Kutluay, Y., Kaya-Yasar, Y., Bozkurt, T. E., Önder, S. Ç., & Sahin-Erdemli, I., (2019). Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice . European-Respiratory-Society (ERS) International Congress, Madrid, Spain
Karaman-Kutluay, YASEMİN Et Al. "Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice," European-Respiratory-Society (ERS) International Congress, Madrid, Spain, 2019
Karaman-Kutluay, YASEMİN Et Al. "Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice." European-Respiratory-Society (ERS) International Congress , Madrid, Spain, 2019
Karaman-Kutluay, Y. Et Al. (2019) . "Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice." European-Respiratory-Society (ERS) International Congress , Madrid, Spain.
@conferencepaper{conferencepaper, author={YASEMİN KARAMAN Et Al. }, title={Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice}, congress name={European-Respiratory-Society (ERS) International Congress}, city={Madrid}, country={Spain}, year={2019}}